Concepedia
Statistics
Publications
29
Citations
881
H-Index
18
Active since
1990
Affiliations
University of Michigan(Current)
Novartis (United States)
Eli Lilly (United States)
UCB Pharma (Belgium)
Pfizer (United States)
Gregory S. Friedrichs is an author at University of Michigan specializing in medicine, pharmacology, and cardiology.
Publications per year
1990–2020
Benchmarking Safety Pharmacology regulatory packages and best practice
Silvana Lindgren, Alan Bass, Richard J. Briscoe et al. · Journal of Pharmacological and Toxicological Methods · 2008 · 107 citations
Pharmacy, Pharmacology, Clinical Pharmacology +10
Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart.
Gregory S. Friedrichs, Kenneth S. Kilgore, Peter J. Manley et al. · Circulation Research · 1994 · 85 citations
Medicine, Cardiology, Pharmacology +13
Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury
Simon Black, Michael Gralinski, Gregory S. Friedrichs et al. · Cardiovascular Research · 1995 · 82 citations
Medicine, Cardiology, Pharmacology +11
Protective Effects of the SOD-mimetic SC-52608 Against Ischemia/Reperfusion Damage in the Rabbit Isolated Heart
Kenneth S. Kilgore, Gregory S. Friedrichs, Connor Johnson et al. · Journal of Molecular and Cellular Cardiology · 1994 · 56 citations · Full text
Medicine, Cardiology, Physiology +10
Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis.
Francis S. Markland, Gregory S. Friedrichs, S. R. Pewitt et al. · Circulation · 1994 · 51 citations · Full text
Medicine, Pharmacology, Clinical Pharmacology +13
1–5 of 29